Following its previous FDA clearance for Type 1 diabetes solution, DreaMed achieves unprecedented validation of its digital endocrinologist expert-care platform.
Read more here.
Following its previous FDA clearance for Type 1 diabetes solution, DreaMed achieves unprecedented validation of its digital endocrinologist expert-care platform.
Read more here.
![[Polarisqb on EIN Presswire] POLARISqb Announces the Release of Quantum Aided Drug Design (QuADD): A Quantum Powered SaaS for Drug Discovery](https://blog.ourcrowd.net/wp-content/themes/Extra/images/post-format-thumb-text.svg)
